Back
ARK Genomic Revolution ETF Vs. Range Cancer Therapeutics ETF Industry Stock Comparison
Buy
64
ARKG
ARK Genomic Revolution ETF
Last Price:
23.84
Seasonality Move:
5.36%
Sell
47
CNCR
Range Cancer Therapeutics ETF
Last Price:
13.62
Seasonality Move:
2.55%
Buy
64
ARK Genomic Revolution ETF (ARKG)
is a Buy
Is ARK Genomic Revolution ETF a Buy, Sell or Hold?
- The current ARK Genomic Revolution ETF [ARKG] share price is $23.83. The Score for ARKG is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
- ARKG is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
47
Range Cancer Therapeutics ETF (CNCR)
is a Sell
Is Range Cancer Therapeutics ETF a Buy, Sell or Hold?
- The current Range Cancer Therapeutics ETF [CNCR] share price is $13.56. The Score for CNCR is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- CNCR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ARKG Stock Price Chart
What is ARK Genomic Revolution ETF's stock price today?
-
The ARK Genomic Revolution ETF share price today is $23.83
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ARKG is experiencing buying pressure, which is a positive indicator for future bullish movement.
CNCR Stock Price Chart
What is Range Cancer Therapeutics ETF's stock price today?
-
The Range Cancer Therapeutics ETF share price today is $13.56
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CNCR is experiencing slight buying pressure.
ARKG Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.32 | Sell |
| Relative Strength Index (14 RSI): | 46.78 | Sell |
| Chaikin Money Flow: | 1743592 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (23.11 - 25.33) | Sell |
| Bollinger Bands (100): | (23.93 - 26.29) | Sell |
CNCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.43 | Sell |
| Relative Strength Index (14 RSI): | 36.72 | Sell |
| Chaikin Money Flow: | 1180 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (13.87 - 15.47) | Sell |
| Bollinger Bands (100): | (14.08 - 15.46) | Sell |
ARKG Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 23.6 | Buy |
| 20-day SMA: | 24.34 | Sell |
| 50-day SMA: | 24.69 | Sell |
| 200-day SMA: | 25.96 | Sell |
| 8-day EMA: | 23.75 | Buy |
| 20-day EMA: | 24.16 | Sell |
| 50-day EMA: | 24.57 | Sell |
| 200-day EMA: | 25.98 | Sell |
CNCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 13.68 | Sell |
| 20-day SMA: | 14.6 | Sell |
| 50-day SMA: | 14.86 | Sell |
| 200-day SMA: | 15.05 | Sell |
| 8-day EMA: | 13.76 | Sell |
| 20-day EMA: | 14.32 | Sell |
| 50-day EMA: | 14.66 | Sell |
| 200-day EMA: | 14.55 | Sell |
ARK Genomic Revolution ETF Earnings Growth & ARKG Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Range Cancer Therapeutics ETF Earnings Growth & CNCR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
ARK Genomic Revolution ETF Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Range Cancer Therapeutics ETF Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||